HAVN Life Sciences HAVLF Stock
HAVN Life Sciences Price Chart
HAVN Life Sciences HAVLF Financial and Trading Overview
| HAVN Life Sciences stock price | 0.0010 USD |
| Previous Close | 0.03 USD |
| Open | 0.02 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.02 - 0.02 USD |
| 52 Week Range | 0.002 - 1.8 USD |
| Volume | 5.84K USD |
| Avg. Volume | 6.6K USD |
| Market Cap | 442.21K USD |
| Beta (5Y Monthly) | -0.502676 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.37 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
HAVLF Valuation Measures
| Enterprise Value | 337.97K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.7533766 |
| Price/Book (mrq) | 0.3877193 |
| Enterprise Value/Revenue | 0.576 |
| Enterprise Value/EBITDA | -0.096 |
Trading Information
HAVN Life Sciences Stock Price History
| Beta (5Y Monthly) | -0.502676 |
| 52-Week Change | -98.29% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.8 USD |
| 52 Week Low | 0.002 USD |
| 50-Day Moving Average | 0.03 USD |
| 200-Day Moving Average | 0.06 USD |
HAVLF Share Statistics
| Avg. Volume (3 month) | 6.6K USD |
| Avg. Daily Volume (10-Days) | 2.15K USD |
| Shares Outstanding | 14.74M |
| Float | 14.58M |
| Short Ratio | N/A |
| % Held by Insiders | 4.74% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | April 30, 2022 |
| Most Recent Quarter (mrq) | January 31, 2023 |
| Next Fiscal Year End | April 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -612.59% |
| Gross Margin | 35.53% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -30.26% |
| Return on Equity (ttm) | -234.52% |
Income Statement
| Revenue (ttm) | 586.98K USD |
| Revenue Per Share (ttm) | 0.08 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 89.69K USD |
| EBITDA | -3502641 USD |
| Net Income Avi to Common (ttm) | -15710916 USD |
| Diluted EPS (ttm) | -2.31 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 13.99K USD |
| Total Cash Per Share (mrq) | 0.001 USD |
| Total Debt (mrq) | 26.23K USD |
| Total Debt/Equity (mrq) | 3.13 USD |
| Current Ratio (mrq) | 2.677 |
| Book Value Per Share (mrq) | 0.057 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2609210 USD |
| Levered Free Cash Flow (ttm) | -708919 USD |
Profile of HAVN Life Sciences
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 2800-666 Burrard Street |
| ZIP | V6C 2Z7 |
| Phone | N/A |
| Website | https://www.havnlife.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.
Q&A For HAVN Life Sciences Stock
What is a current HAVLF stock price?
HAVN Life Sciences HAVLF stock price today per share is 0.0010 USD.
How to purchase HAVN Life Sciences stock?
You can buy HAVLF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for HAVN Life Sciences?
The stock symbol or ticker of HAVN Life Sciences is HAVLF.
Which industry does the HAVN Life Sciences company belong to?
The HAVN Life Sciences industry is Biotechnology.
How many shares does HAVN Life Sciences have in circulation?
The max supply of HAVN Life Sciences shares is 326.45M.
What is HAVN Life Sciences Price to Earnings Ratio (PE Ratio)?
HAVN Life Sciences PE Ratio is now.
What was HAVN Life Sciences earnings per share over the trailing 12 months (TTM)?
HAVN Life Sciences EPS is -4.37 USD over the trailing 12 months.
Which sector does the HAVN Life Sciences company belong to?
The HAVN Life Sciences sector is Healthcare.